Heart Failure, Diastolic
87
13
19
46
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
20 trials with published results (23%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
4.6%
4 terminated out of 87 trials
92.0%
+5.5% vs benchmark
17%
15 trials in Phase 3/4
43%
20 of 46 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 46 completed trials
Clinical Trials (87)
Incretin Therapies in Obesity-related HFpEF
Pilot Study Lp299v Supplementation in Chronic Heart Failure
A Study of LY3971297 in Participants With Heart Failure
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RESPONDER-HF Trial
Data-Driven Phenotyping in Heart Failure With Preserved Ejection Fraction
External Body Pressure in Heart Failure With Preserved Ejection Fraction
Predicting Heart Failure Outcomes With Biomarkers and Imaging
Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status
A Preliminary Study for INFORMED
A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction
Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure
Chronic Exogenous Ketosis in HFpEF
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
Hemodynamic-GUIDEd Management of Heart Failure
HIDRAdenitis Suppurativa and HEART Disease
Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction
AB-1002 in Patients With Class III Heart Failure
Cardiac Structure and Function in Patients with Cystic Fibrosis
Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction